Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Codexis Inc (CDXS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 410,975
  • Shares Outstanding, K 48,350
  • Annual Sales, $ 48,840 K
  • Annual Income, $ -8,560 K
  • 36-Month Beta -1.59
  • Price/Sales 9.87
  • Price/Cash Flow N/A
  • Price/Book 18.81

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.75 +9.68%
on 12/22/17
9.45 -10.05%
on 01/11/18
+0.65 (+8.28%)
since 12/18/17
3-Month
5.70 +49.12%
on 11/15/17
9.45 -10.05%
on 01/11/18
+1.20 (+16.44%)
since 10/18/17
52-Week
3.60 +136.11%
on 02/24/17
9.45 -10.05%
on 01/11/18
+3.70 (+77.08%)
since 01/18/17

Most Recent Stories

More News
Codexis Reports Financial Results for the Third Quarter of 2017

Product sales increase 71% over the prior year

CDXS : 8.50 (-1.16%)
Codexis, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 9, 2017 / Codexis, Inc. (NASDAQ: CDXS) will be discussing their earnings results in their Q3 Earnings Call to be held on November 9, 2017 at 4:30 PM Eastern Time.

CDXS : 8.50 (-1.16%)
Codexis to Present at Two Investment Conferences in November

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at two investment conferences in November:

CDXS : 8.50 (-1.16%)
Codexis to Hold 2017 Third Quarter Conference Call on November 9

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report third quarter 2017 financial results after market close on Thursday, November 9, 2017. Codexis management...

CDXS : 8.50 (-1.16%)
Codexis and Nestle Health Science Enter Into Healthcare-Focused Protein Engineering Platform Partnership

-- Includes an option for the global development of CDX-6114 for PKU, marking Codexis' first partnership for an internally developed biotherapeutic product. Codexis receives an upfront payment of $14...

CDXS : 8.50 (-1.16%)
Codexis to Present at Four Investment Conferences in September

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at four investment conferences in September:

CDXS : 8.50 (-1.16%)
EnzymeWorks, Inc. and Dr. Alex Tao Respond to Press Release by Codexis, Inc.

In response to a recent inaccurate press release by Codexis regarding the case Codexis, Inc. v. EnzymeWorks, Inc., Case No. 3:16-cv-00826-WHO (the "Case"), EnzymeWorks and Alex Tao, Ph.D.,...

CDXS : 8.50 (-1.16%)
Codexis Reports Financial Results for the Second Quarter of 2017

Product sales more than doubled versus prior-year second quarter

CDXS : 8.50 (-1.16%)
Investor Network: Codexis, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 9, 2017 / Codexis, Inc. (NASDAQ: CDXS) will be discussing their earnings results in their Q2 Earnings Call to be held on Wednesday, August 9, 2017 at 4:30 PM Eastern...

CDXS : 8.50 (-1.16%)
Codexis Obtains Court Order Awarding Summary Judgment of Patent Infringement against EnzymeWorks

Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, on Tuesday secured a federal court order awarding it summary judgment on 10 claims of patent infringement it brought...

CDXS : 8.50 (-1.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. Codexis' proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective...

See More

Key Turning Points

2nd Resistance Point 8.72
1st Resistance Point 8.61
Last Price 8.50
1st Support Level 8.38
2nd Support Level 8.27

See More

52-Week High 9.45
Last Price 8.50
Fibonacci 61.8% 7.22
Fibonacci 50% 6.52
Fibonacci 38.2% 5.83
52-Week Low 3.60

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.